Celltrion

This study tested whether adding pioglitazone to two common diabetes drugs (metformin and empagliflozin) helps lower blood sugar more effectively. About 600 adults with type 2 diabetes whose blood sugar was not well controlled took either pioglitazone or a placebo for several wee…

This study tested a drug called CT-P13, given as a shot under the skin, in 192 adults with moderate-to-severe rheumatoid arthritis. The goal was to see if it reduces joint pain and swelling better than a placebo. Participants received either the drug or a dummy shot, and neither …

This study tested whether taking two blood pressure medicines together works better than taking either one alone. About 890 adults with mild-to-moderate high blood pressure took part. The goal was to see if the combination lowers blood pressure more effectively and safely over 8 …

This study tested two different ways to give a single dose of the drug CT-P43 to 162 healthy men aged 19 to 55. One group used an auto-injector, the other a pre-filled syringe. The goal was to see if the drug levels in the blood, safety, and immune response were similar between t…

This early-phase study tested how two experimental drugs (L03RD1 and L03RD2) move through the body and their safety when given together or as a single combined drug (CT-L03). It involved 49 healthy adults aged 19-55. The goal was to gather basic information, not to treat diabetes…

This early-stage study tested the safety and how the body processes two experimental drugs (CTL0201 and CTL0202) given together or alone. Forty healthy adults aged 19 to 55 took a single dose and were monitored. The goal was to gather safety information, not to treat any disease.

This study tested a new drug called CT-P6 against the approved drug Herceptin in 200 healthy men. The goal was to see if the body processes both drugs similarly and to check for side effects. Participants received a single injection under the skin.